SAR444200
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for SAR444200, covering 2026-01-14 to 2026-01-14. Get the full timeline:
Most recent: Clinical Trial Update: Dose Escalation and Expansion Study of SAR444200-based Regimen in Adult Participants With Advanced Solid Tumors [Phase 1, Phase 2]